arrow
P

Paolo Muto

department of radiation oncology
H指数:29
被引数:3,290

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of whole-brain radiation therapy on neurocognitive functions, alopecia and hearing loss: a systematic review and meta-analysis endorsed by the Palliative Care and Neuro-Oncology Study Groups of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

全脑放射治疗对神经认知功能、脱发和听力损失的影响:一项由意大利放射治疗与临床肿瘤学会(AIRO)姑息治疗与神经肿瘤学研究组支持的系统评价和Meta分析

2025-11-080
PRE
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
2024-06-0111
PRE
Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial
2023-11-072
OAAI
Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

来自胃肠道的寡转移肿瘤: 临床和分子驱动因素的鉴定: 预测研究

2023-10-190
OAAI
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
2023-02-239
OAAI
Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis

转移性黑色素瘤患者的Nivolumab血清浓度可能与预后和增强的免疫活性有关: 基因分析回顾性分析

2022-11-245
OAAI
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy

Pro-epi的早期结果: 对接受根治性,辅助或挽救性放疗伴或不伴雄激素剥夺治疗的中/高/极高危非转移性前列腺癌患者选择性盆腔淋巴结照射的前瞻性多中心观察性研究

2022-11-022
OAAI
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization

西替利嗪联合治疗晚期黑色素瘤可通过促进M1巨噬细胞极化增强anti-PD-1疗效

2022-09-3016
OAAI
Lurbinectedin in small cell lung cancer
2022-08-3015
OAAI
Life style and interaction with microbiota in prostate cancer patients undergoing radiotherapy: study protocol for a randomized controlled trial
2022-07-194
OAAI
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial

寡电流淋巴结前列腺癌: 随机PEACE v-storm II期试验的放射治疗质量保证

2022-07-014
OAAI
Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model
2021-09-2730
OAAI
Oligometastatic prostate cancer treatment
2021-07-232
PRE
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO

免疫疗法联合立体定向放射治疗非小细胞肺癌脑转移: 代表AIRO的多中心回顾性研究结果

2021-05-2945
OA